Keep up-to-date with us

Category: Stratifying patient cohorts

Volv Global stratifies patient groups with AI—helping segment, cluster, and target cohorts for better trials and treatments.

News article: When science fiction becomes science fact – AI for rare disease diagnosis

- 02/04/2026

Advocacy in rare disease: Driving technology advances – 2023 Webinar

- 02/03/2026

Uncovering the uncommon: Advances in Rare Disease diagnosis – 2024 Podcast

- 05/02/2026

Chronic Obstructive Pulmonary Disease: Why We Need Better Patient Identification for 21st-Century Treatments

- 28/01/2026

The Patient Voice and AI-Driven Healthcare – Guest Article by Rare Patient Voice

- 22/01/2026

MASH/NASH: Why Therapeutic Breakthroughs Demand a New Era of Patient Identification

- 05/12/2025

Unlocking the Future of Type 1 Diabetes Care: Why Earlier Diagnosis Must Match Innovation in Treatment

- 15/10/2025

News Article: AI in healthcare

- 12/09/2025

Beyond Quick Fixes: How Predictive Modelling Can Redefine Clinical Trial Enrolment

- 21/08/2025

Beyond Initial Treatment: Navigating Recurrence Risk and Clinical Decisions in Cancer Survivors

- 08/07/2025